[1]
Derudas, D. 2025. Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS. Mediterranean Journal of Hematology and Infectious Diseases. 17, 1 (Feb. 2025), e2025025. DOI:https://doi.org/10.4084/MJHID.2025.025.